Navigation Links
Transdel Enrolls First Patient for Ketotransdel(TM) Phase 3 Clinical Trial
Date:9/22/2008

LA JOLLA, Calif., Sept. 22 /PRNewswire-FirstCall/ -- Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), a specialty pharmaceutical company focused on developing non-invasive, topically administered medications, today announced it has enrolled its first patient in the Phase 3 registration trial for Ketotransdel(TM). Ketotransdel(TM), a novel analgesic and anti-inflammatory topical cream, contains 10% ketoprofen (a non-steroidal anti-inflammatory drug, "NSAID"), and is intended for use in the treatment of acute pain from musculoskeletal conditions.

The Ketotransdel(TM) Phase 3 registration study entitled: "A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study to Assess the Efficacy and Safety of Ketotransdel(TM) in the Treatment of Pain Associated with Mild to Moderate Acute Soft Tissue Injury," will be conducted at approximately 25 to 35 sites in the United States and potentially in Canada. The Company expects to enroll approximately 350 patients of which 50% will be provided Ketotransdel(TM) and 50% a placebo vehicle. The Phase 3 study currently has three sites that are actively screening for patients. It is expected that the majority of the sites will be activated during October and November. The Company expects to report top-line results in the second half of 2009.

In the Phase 3 study, the primary efficacy endpoint will be the difference in the change of baseline pain between Ketotransdel(TM) and placebo at Day 3. This endpoint is measured by using the Visual Analogue Scale (VAS), a validated and widely used scale for recording pain which 0 indicates "no pain" and 100 indicates "the worst imaginable pain." The secondary endpoints will include safety assessments and other efficacy parameters measured by VAS at Day 3 and Day 7. In addition to evaluating for efficacy and safety over the one week period, the study will also assess safety at one week post-treatment.

"We are excited about reaching
'/>"/>

SOURCE Transdel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program
2. Transdel Initiates Ketotransdel(TM) Phase 3 Clinical Program for Pain
3. Spectranetics Enrolls First Patient in PATENT Trial for the Treatment of Instent Restenosis
4. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
5. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
6. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
7. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
8. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
9. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... -- Diseases largely eradicated in the United ... was declared eliminated in 2000, yet the CDC reports ... highest incidence in 20 years. In July, ... a problem of "epidemic proportions." ... these preventable diseases—in part because some parents (more than ...
(Date:8/29/2014)... Research and Markets has announced ... Market 2014-2018" report to their offering. ... that results in demyelination, axonal transection, and neurodegeneration. The ... by the immune system, which targets neurons within the ... disease in which the damage of the myelin sheath ...
(Date:8/29/2014)... PASO ROBLES, Calif. , Aug. 29, 2014 /PRNewswire/ ... launch of its new website design . The ... an overhaul that showcases the company,s new services and ... By implementing a new streamlined design, viewers can ... deliver metrics for health care practices and create a ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3PMDS Announces New Website 2
... 2012 Kimberly-Clark Professional*, a global leader in contamination ... leading recycler, today announced that they are expanding the ... include a pilot program for gloves after reaching key ... Since the program,s launch in October 2011, participating ...
... April 18, 2012  UCB, a leading biopharmaceutical company committed ... will sponsor multiple sets of key epilepsy data at ... Neurology (AAN) in New Orleans from April 21-28.  The ... antiepileptic drug (AED) Vimpat® (lacosamide) C-V, including updated health-related ...
Cached Medicine Technology:Kimberly-Clark Professional* and TerraCycle Expand Industry's First Cleanroom and Laboratory Garment Recycling Initiative to Include Pilot Program for Gloves 2Kimberly-Clark Professional* and TerraCycle Expand Industry's First Cleanroom and Laboratory Garment Recycling Initiative to Include Pilot Program for Gloves 3Kimberly-Clark Professional* and TerraCycle Expand Industry's First Cleanroom and Laboratory Garment Recycling Initiative to Include Pilot Program for Gloves 4UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 2UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 3UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 4UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 5UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 6UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 7UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 8UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 9
(Date:8/29/2014)... 29, 2014 The Enchant Him review that ... program actually is a system that promises to teach ladies ... created by Carrie Engel, who actually is a popular relationship ... will get the best advices out there, Carrie worked at ... , This new program is a simple to use step ...
(Date:8/29/2014)... Berlin, MD (PRWEB) August 30, 2014 ... provided by the Doctors in Delaware at ... variety of free health-related services. In addition to no-cost ... in Maryland offers first aid care at local sports ... and other medical staff provide free disease management ...
(Date:8/29/2014)... Colorado (PRWEB) August 29, 2014 According to ... a popular way to lose weight quickly, safely and naturally. ... it claims to be amazingly fast, too. , Daily ... new method will not only teach patients how to eliminate ... maintain the desired results when it comes to body modeling. ...
(Date:8/29/2014)... Daily Gossip reveals in its Stop Sciatica in ... of naturally curing this disease. , The program promises ... cure in only one week. This is described as a ... huge sacrifices. , Moreover, with this new method patients ... sciatica in just 8 minutes. , Interested customers can ...
(Date:8/29/2014)... CA (PRWEB) August 29, 2014 Cosmetic ... expert knowledge and authenticity of its doctors. Cosmetic ... only the most renowned doctors in their field are ... to assure patients have a direct link to potentially ... and doctors will be able to communicate through the ...
Breaking Medicine News(10 mins):Health News:Enchant Him Review Reveals Unique Relationship Tips for Women 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 3Health News:Flat Belly Forever Review Exposes the Way to Eliminate Body Fat Easily 2Health News:Stop Sciatica in 8 Minutes Review Exposes Steven Guo's Complete Sciatica Cure 2Health News:Cosmetic Town Now Advocates for the Rights of Cosmetic Patients Using Novel Approach 2
... , THURSDAY, April 14 (HealthDay News) -- Male humpback whales ... Within regional populations of the whales, males all sing ... changes over time, with new versions spreading across the ocean ... study published online April 14 in the journal Current ...
... , THURSDAY, April 14 (HealthDay News) -- Family behavior ... study contends. Researchers in Croatia assessed what they ... mental state in response to actual or anticipated pain. ... of their spouses and 100 of their first-born adult ...
... ways that nutrients or diets may lessen the effects ... the U.S. Department of Defense might be able to ... TBI. Nutrition and Traumatic Brain Injury: Improving ... new report from the Institute of Medicine, recommends which ...
... News) -- Trying to make the best of the situation and ... their jobs, a new United Kingdom study finds. The researchers ... loss were able to see the event as a new era ... They also took a contemplative view of their job loss ...
... Giving patients data about the risks and benefits of a ... them to irrational decisions, according to an article in the ... whether it is essential to disclose quantitative data to patients ... for experimental evidence to determine the best way to provide ...
... researchers at the University of Cincinnati (UC) shows that ... not using spiritual coping and often use complementary and ... to manage symptoms. These findings, being presented ... Antonio April14-16, could help physicians and other providers gain ...
Cached Medicine News:Health News:Whales Not Just Singing the Same Old Song, Researchers Say 2Health News:Good Attitude Critical When Coping With Layoff Trauma 2Health News:Too Much Information? Risk-benefit data does not always lead to informed decision-making 2Health News:Too Much Information? Risk-benefit data does not always lead to informed decision-making 3Health News:Integrative medicine, spirituality improves outcomes in urban adolescents with asthma 2Health News:Integrative medicine, spirituality improves outcomes in urban adolescents with asthma 3Health News:Integrative medicine, spirituality improves outcomes in urban adolescents with asthma 4
... system facilitates bedside labeling of all ... bank and nursing personnel where the ... The combination admitting ID band and ... patient identification system in facilities where ...
... Location Receiver is an optional component ... to outdoor and difficult environments. AeroScout ... location measurement capabilities packaged in small, ... harsh conditions. The Location Receiver receives ...
Integrate RFID and bar code technology with the new DR1000 Dual RFID/Bar Code Reader by Precision Dynamics Corporation (PDC). It provides an easy migration from bar codes to RFID tags for healthcare ...
... SATO RFID printer reads, writes and prints ... visual image, text or barcode on the ... are ideal for a range of applications, ... Asset Tracking, Baggage Tagging, Retail Labeling, Product ...
Medicine Products: